Split History
SRPT split history picture
Sarepta Therapeutics (SRPT) has 1 split in our SRPT split history database. The split for SRPT took place on July 12, 2012. This was a 1 for 6 reverse split, meaning for each 6 shares of SRPT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 166.666666666667 share position following the split.

When a company such as Sarepta Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the SRPT split history from start to finish, an original position size of 1000 shares would have turned into 166.666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Sarepta Therapeutics shares, starting with a $10,000 purchase of SRPT, presented on a split-history-adjusted basis factoring in the complete SRPT split history. SRPT split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/25/2014
End date: 06/21/2024
Start price/share: $30.41
End price/share: $160.72
Dividends collected/share: $0.00
Total return: 428.51%
Average Annual Total Return: 18.12%
Starting investment: $10,000.00
Ending investment: $52,848.93
Years: 10.00
Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on helping patients through the discovery and development of RNA-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. Co. is developing therapeutic candidates for a range of diseases and disorders, including Duchenne muscular dystrophy, Limb-girdle muscular dystrophies and other neuromuscular and central nervous system related disorders. Co.'s commercial product, EXONDYS 51® (eteplirsen) Injection is indicated for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping. According to our SRPT split history records, Sarepta Therapeutics has had 1 split.
Date Ratio
07/12/20121 for 6
SRPT is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

SRRA Split History
SSH Split History
SSKN Split History
STAA Split History
STE Split History
STEM Split History
STJ Split History
STXS Split History
SURG Split History
SYBX Split History

Also explore: SRPT shares outstanding history

Email EnvelopeFree SRPT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Crown Electrokinetics Corp. (CRKN)
Medalist Diversified REIT, Inc. (MDRR)
Medalist Diversified REIT, Inc. (MDRR)
Qilian International Holding Group Limited (QLI)
Bluejay Diagnostics, Inc. (BJDX)
Atara Biotherapeutics, Inc. (ATRA)
GRI Bio, Inc. (GRI)
Williams-Sonoma, Inc. (WSM)
Workhorse Group Inc. (WKHS)
Virgin Galactic Holdings, Inc. (SPCE)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

SRPT Insider Buying

SRPT Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.